Prenatal Ritodrine Administration and the Incidence of Respiratory Distress Syndrome in Premature Infants

E. Kerem, S. Dollberg, I. Paz, Y. Armon, Daniel S. Seidman, D. K. Stevenson, R. Gale

Research output: Contribution to journalArticle

Abstract

Prenatal exposure to ritodrine may be associated with a lower incidence of RDS in premature infants, independent of its effect on prolongation of pregnancy. OBJECTIVE: The purpose of this study was to assess the neonatal respiratory outcome of premature infants according to whether their mothers were treated prenatally with ritodrine. STUDY DESIGN: A retrospective review was done of all 247 infants born at 34 weeks of gestation or less in our hospital during a 6-year period. A multivariate logistic regression was used to adjust for possible confounding variables. RESULTS: Among the ritodrine-exposed infants respiratory distress syndrome developed in 9.5% (4/42) compared with 28% (57/205) in the unexposed group (p <0.012; adjusted odds ratio 4.88, 95% confidence interval 1.27 to 18.70). The gestational age and birth weight were similar in the two groups. The incidence of transient tachypnea of the newborn and other neonatal complications was not statistically different between the two groups. CONCLUSION: Ritodrine was associated with a significantly lower incidence of respiratory distress syndrome in premature infants, independent of the effect of ritodrine on prolongation of pregnancy.

Original languageEnglish (US)
Pages (from-to)101-106
Number of pages6
JournalJournal of perinatology : official journal of the California Perinatal Association
Volume17
Issue number2
StatePublished - Mar 1997
Externally publishedYes

Fingerprint

Ritodrine
Incidence
Premature Infants
Pregnancy
Transient Tachypnea of the Newborn
Newborn Respiratory Distress Syndrome
Confounding Factors (Epidemiology)
Birth Weight
Gestational Age
Logistic Models
Odds Ratio
Mothers
Respiratory Distress Syndrome In Premature Infants
Confidence Intervals

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Prenatal Ritodrine Administration and the Incidence of Respiratory Distress Syndrome in Premature Infants. / Kerem, E.; Dollberg, S.; Paz, I.; Armon, Y.; Seidman, Daniel S.; Stevenson, D. K.; Gale, R.

In: Journal of perinatology : official journal of the California Perinatal Association, Vol. 17, No. 2, 03.1997, p. 101-106.

Research output: Contribution to journalArticle

Kerem, E. ; Dollberg, S. ; Paz, I. ; Armon, Y. ; Seidman, Daniel S. ; Stevenson, D. K. ; Gale, R. / Prenatal Ritodrine Administration and the Incidence of Respiratory Distress Syndrome in Premature Infants. In: Journal of perinatology : official journal of the California Perinatal Association. 1997 ; Vol. 17, No. 2. pp. 101-106.
@article{87cd2080720d41f79a3542836950d4c2,
title = "Prenatal Ritodrine Administration and the Incidence of Respiratory Distress Syndrome in Premature Infants",
abstract = "Prenatal exposure to ritodrine may be associated with a lower incidence of RDS in premature infants, independent of its effect on prolongation of pregnancy. OBJECTIVE: The purpose of this study was to assess the neonatal respiratory outcome of premature infants according to whether their mothers were treated prenatally with ritodrine. STUDY DESIGN: A retrospective review was done of all 247 infants born at 34 weeks of gestation or less in our hospital during a 6-year period. A multivariate logistic regression was used to adjust for possible confounding variables. RESULTS: Among the ritodrine-exposed infants respiratory distress syndrome developed in 9.5{\%} (4/42) compared with 28{\%} (57/205) in the unexposed group (p <0.012; adjusted odds ratio 4.88, 95{\%} confidence interval 1.27 to 18.70). The gestational age and birth weight were similar in the two groups. The incidence of transient tachypnea of the newborn and other neonatal complications was not statistically different between the two groups. CONCLUSION: Ritodrine was associated with a significantly lower incidence of respiratory distress syndrome in premature infants, independent of the effect of ritodrine on prolongation of pregnancy.",
author = "E. Kerem and S. Dollberg and I. Paz and Y. Armon and Seidman, {Daniel S.} and Stevenson, {D. K.} and R. Gale",
year = "1997",
month = "3",
language = "English (US)",
volume = "17",
pages = "101--106",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Prenatal Ritodrine Administration and the Incidence of Respiratory Distress Syndrome in Premature Infants

AU - Kerem, E.

AU - Dollberg, S.

AU - Paz, I.

AU - Armon, Y.

AU - Seidman, Daniel S.

AU - Stevenson, D. K.

AU - Gale, R.

PY - 1997/3

Y1 - 1997/3

N2 - Prenatal exposure to ritodrine may be associated with a lower incidence of RDS in premature infants, independent of its effect on prolongation of pregnancy. OBJECTIVE: The purpose of this study was to assess the neonatal respiratory outcome of premature infants according to whether their mothers were treated prenatally with ritodrine. STUDY DESIGN: A retrospective review was done of all 247 infants born at 34 weeks of gestation or less in our hospital during a 6-year period. A multivariate logistic regression was used to adjust for possible confounding variables. RESULTS: Among the ritodrine-exposed infants respiratory distress syndrome developed in 9.5% (4/42) compared with 28% (57/205) in the unexposed group (p <0.012; adjusted odds ratio 4.88, 95% confidence interval 1.27 to 18.70). The gestational age and birth weight were similar in the two groups. The incidence of transient tachypnea of the newborn and other neonatal complications was not statistically different between the two groups. CONCLUSION: Ritodrine was associated with a significantly lower incidence of respiratory distress syndrome in premature infants, independent of the effect of ritodrine on prolongation of pregnancy.

AB - Prenatal exposure to ritodrine may be associated with a lower incidence of RDS in premature infants, independent of its effect on prolongation of pregnancy. OBJECTIVE: The purpose of this study was to assess the neonatal respiratory outcome of premature infants according to whether their mothers were treated prenatally with ritodrine. STUDY DESIGN: A retrospective review was done of all 247 infants born at 34 weeks of gestation or less in our hospital during a 6-year period. A multivariate logistic regression was used to adjust for possible confounding variables. RESULTS: Among the ritodrine-exposed infants respiratory distress syndrome developed in 9.5% (4/42) compared with 28% (57/205) in the unexposed group (p <0.012; adjusted odds ratio 4.88, 95% confidence interval 1.27 to 18.70). The gestational age and birth weight were similar in the two groups. The incidence of transient tachypnea of the newborn and other neonatal complications was not statistically different between the two groups. CONCLUSION: Ritodrine was associated with a significantly lower incidence of respiratory distress syndrome in premature infants, independent of the effect of ritodrine on prolongation of pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0031090471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031090471&partnerID=8YFLogxK

M3 - Article

C2 - 9134506

AN - SCOPUS:0031090471

VL - 17

SP - 101

EP - 106

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 2

ER -